LUNASERA Trademark

Trademark Overview


On Monday, February 12, 2024, a trademark application was filed for LUNASERA with the United States Patent and Trademark Office. The USPTO has given the LUNASERA trademark a serial number of 98401696. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, December 12, 2024. This trademark is owned by PLT HEALTH SOLUTIONS - LAILA NUTRACEUTICALS, LLC. The LUNASERA trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Nutraceuticals for use as a dietary supplement; Herbal supplements for use as ingredients in the food and pharmaceutical industry for the purpose of general wellness; food supplements; Botanical extracts sold as integral components of dietary and nutritional supplements.

Vitamins for manufacturing use; Ingredients and extracts, other than essential oils, for use in the manufacture of dietary and nutritional supplements, namely Botanical extracts; Plant extracts, other than essential oils, for use in the manufacture of dietary and nutritional supplements; Vitamins for use in the manufacture of food supplements

General Information


Serial Number98401696
Word MarkLUNASERA
Filing DateMonday, February 12, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, December 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesNutraceuticals for use as a dietary supplement; Herbal supplements for use as ingredients in the food and pharmaceutical industry for the purpose of general wellness; food supplements; Botanical extracts sold as integral components of dietary and nutritional supplements.
Goods and ServicesVitamins for manufacturing use; Ingredients and extracts, other than essential oils, for use in the manufacture of dietary and nutritional supplements, namely Botanical extracts; Plant extracts, other than essential oils, for use in the manufacture of dietary and nutritional supplements; Vitamins for use in the manufacture of food supplements

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, February 12, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePLT HEALTH SOLUTIONS - LAILA NUTRACEUTICALS, LLC
Party Type10 - Original Applicant
Legal Entity Type05 - Joint Venture
AddressMorristown, NJ 07960

Trademark Events


Event DateEvent Description
Monday, February 12, 2024NEW APPLICATION ENTERED
Tuesday, June 11, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 5, 2024ASSIGNED TO EXAMINER
Thursday, September 12, 2024NON-FINAL ACTION E-MAILED
Thursday, September 12, 2024NON-FINAL ACTION WRITTEN
Thursday, September 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED